Medicine composition used for treating hemiplegia and cerebral thrombus

A technology for hemiplegia and cerebral thrombosis, applied in the direction of drug combination, effective ingredients of hydroxyl compounds, medical raw materials derived from molluscs, etc., can solve the problems of drug withdrawal recurrence, toxic and side effects, etc.

Active Publication Date: 2009-12-30
JILIN ZIXIN PHARMA
View PDF0 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, many chemical drugs are used in the treatment of the above-mentioned cerebrovascular diseases, but due to problems such as drug withdrawal recurrence

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicine composition used for treating hemiplegia and cerebral thrombus
  • Medicine composition used for treating hemiplegia and cerebral thrombus
  • Medicine composition used for treating hemiplegia and cerebral thrombus

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0078] The preparation of embodiment 1 tablet of the present invention

[0079] Astragalus total flavonoids 10g, red ginseng glycosides 1g, angelica volatile oil 1g, red paeony glucosides 1g, gastroside 1g, Atractylodes macrocephala volatile oil 1g, scrophulariaceae glycosides 1g, alisma glycosides 1g, scorpion 0.1g, agarwood resin 0.1g , total woody saponins 0.1g, borneol 0.1g, total epimedi glycosides 5g, notoginseng saponins 1g, safflower glycosides 1g, amygdalin 3g, agrimonin 1g, dannanxing triterpenoid saponins 1g, coptis berberine 1g, Chuanxiong ferulic acid 1g, Polygonum multiflorum emodin 1g, Aconite saponin 1g, Bombyx mori ecdysterol 0.1g, Pearl calcium carbonate 1g, Shichangpu essential oil 10g, Dilongwormin 1g, Fanghe base 1g, Shijue 1g gentianin, 1g sophoside, 1g total flavonoids of kudzu root, 1g forsythia glycosides, 1g ethanol extract of wolfberry fruit, 1g cassia seed polysaccharide, 0.1g volatile oil of asarum, 0.1g saponin of pig tooth saponin, 0.1g volatile ...

Embodiment 2

[0116] The preparation of embodiment 2 capsules of the present invention

[0117] Astragalus total flavonoids 15g, red ginseng glycosides 3g, angelica volatile oil 3g, red paeony glycosides 3g, gastroside 3g, Atractylodes rhizome volatile oil 3g, scrophulariaceae glycosides 3g, alisma glycosides 3g, scorpion 1.5g, agarwood resin 2.5g , total woody saponins 2.5g, borneol 2.5g, total epimedi glycosides 10g, notoginseng saponins 3g, safflower glycosides 3g, amygdalin 9g, agrimonin 3g, dannanxing triterpenoid saponins 3g, coptis berberine 3g, Chuanxiong ferulic acid 3g, Polygonum multiflorum emodin 3g, Aconite saponin 3g, Bombyx mori ecdysterol 1.5g, pearl calcium carbonate 2g, Shichangpu essential oil 15g, earthworm element 3g, tetrandrine 3g, Cassia chinensis Choline 3g, Sophoraside 3g, Pueraria total flavonoids 3g, Forsythia glycosides 3g, Lycium barbarum ethanol extract 3g, Cassia seed polysaccharide 3g, Asarum volatile oil 2.5g, Suya saponin 2.5g, Rhubarb volatile oil 2.5g. ...

Embodiment 3

[0119] The preparation of embodiment 3 granules of the present invention

[0120] Astragalus total flavonoids 20g, red ginseng glycosides 5g, angelica volatile oil 5g, red paeony glycosides 5g, gastroside 5g, Atractylodes rhizome volatile oil 5g, scrophulariaceae glycosides 5g, alisma glycosides 5g, scorpion 3g, agarwood resin 5g, wood 5g total saponins, 5g borneol, 15g total epimedium glucosides, 5g notoginseng saponins, 5g safflower glycosides, 15g amygdalin, 5g agrimonin, 5g dannanxing triterpene saponins, 5g coptis berberine, chuanxiong A 5g of ferulic acid, 5g of emodin from Polygonum multiflorum, 5g of white aconite saponin, 3g of ecdysterol, 3g of pearl calcium carbonate, 20g of calamus essential oil, 5g of earthworm element, 5g of antihexine, 5g of cassia gallin, Sophorin 5g, Pueraria total flavonoids 5g, Forsythia glycosides 5g, Lycium barbarum ethanol extract 5g, Cassia seed polysaccharide 5g, Asarum volatile oil 5g, Suyasaponin 5g, Rhubarb volatile oil 5g.

[0121]...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a medicine composition used for treating hemiplegia and cerebral thrombus, belonging to the traditional Chinese medicine. The medicine composition comprises the following active substances: 10 to 20 parts of astragalus root total flavone, 10 to 20 parts of japanese sweetflag essential oil, 1 to 5 parts of red ginseng total glucoside, 1 to 5 parts of angelica volatile oil, 1 to 5 parts of red peony root total glucoside, 1 to 5 parts of gastrodin, 1 to 5 parts of white atractylodes rhizome volatile oil, 1 to 5 parts of figwort total glucoside, 1 to 5 parts of rhizoma alismatis total glucoside, 1 to 5 parts of radix notoginseng glucoside, 1 to 5 parts of safflower glycoside, 1 to 5 parts of agrimony glycoside, 1 to 5 parts of arisaema cum bile triterpenoid saponin, 1 to 5 parts of coptis root xanthoplcrite, 1 to 5 parts of rhizoma ligustici wallichii ferulic acid, 1 to 5 parts of prepared tuber fleeceflower emodin, 1 to 5 parts of rhizoma typhonii glucoside, 1 to 5 parts of earthworm lumbricin, 1 to 5 parts of menispermine, 1 to 5 parts of sea-ear shell gallbladder essence, 1 to 5 parts of sophora flower glycoside, 1 to 5 parts of radix puerariae total flavone, 1 to 5 parts of weeping forsythia total glycoside, 1 to 5 parts of medlar alcohol extract, 1 to 5 parts of cassia seed polysaccharide, 0.1 to 3 parts of scorpio, 0.1 to 3 parts of muscardine silkworm ecdysis-promoting sterol, 0.1 to 5 parts of lignum aloe resin, 0.1 to 5 parts of rosa banksiae total glucoside, 0.1 to 5 parts of borneol, 0.1 to 5 parts of wild ginger volatile oil, 0.1 to 5 parts of fructus gleditsiae abnormalis saponin, 0.1 to 5 parts of rhubarb volatile oil, 5 to 15 parts of herba epimedii total glucoside, 3 to 15 parts of bitter apricot seed glycoside and 1 to 3 parts of pearl calcium carbonate. The medicine composition is used for treating dottiness, unlucky and astringent mood, limb spasm, hemiplegia, cerebral thrombus and sequelae thereof.

Description

technical field [0001] The invention belongs to a traditional Chinese medicine, in particular, it is used for the treatment of confusion, slurred tone, spasms of hands and feet, hemiplegia, cerebral thrombosis and its sequelae, and has the functions of dissolving phlegm and refreshing the brain, and dispelling wind and fire collaterals. Background technique [0002] As cerebrovascular disease seriously endangers public health, cerebrovascular disease has surpassed cancer and ranked first among the causes of death in my country. In economically developed countries and regions such as Europe, America and Japan, cardiovascular disease ranks first among the causes of death from public diseases, and cerebrovascular disease ranks second. At present, many chemical drugs are used for the treatment of the above-mentioned cerebrovascular diseases, but due to the problems of drug withdrawal and recurrence and toxic and side effects, it is still necessary to further develop an ideal dru...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/8884A61K36/8988A61P9/10A61P7/02A61K31/045A61K31/122A61K31/192A61K31/4375A61K31/485A61K31/575A61K31/7028A61K31/7034A61K31/715A61K33/10A61K35/56A61K35/64A61K35/618A61K35/62A61K35/646
Inventor 郭春生殷金龙李宝芝张佩华
Owner JILIN ZIXIN PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap